Qiagen NV | QIA - Equity Capital And Reserves

Stock Price
35.03
Daily Change
-0.41 -1.14%
Monthly
-5.44%
Yearly
-0.55%
Q2 Forecast
34.40

Qiagen NV reported $3.78B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
argenx SE USD 6.1B 597.47M Jun/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025